PTIX · Protagenic Therapeutics, Inc.\new · Share Buybacks
$0.57
-0.17 (-22.97%)
At close · Jan 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not have sufficient resources to fund its operations past twelve months from the date these consolidated financial statements are available to be issued. The Company expects that additional capital may be required during the next 12 months to continue executing its business plan and to meet its obligations as they become due. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.45M
Shares
1.81M
Volume · Jan 5
580.9K
Avg daily vol (3M)
120.04K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-07 | — | $10,000,000 | $1,000,000 as of 2025-12-31 | — | 10-Q , filed 2026-03-09 |
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2010-09-30 | $0 Δ | 10-Q, filed 2011-11-14 |